Depressed and a co-morbid condition: more psychotropics prescribed!

Centre for Quality of Care Research (WOK), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.
The European journal of general practice 02/2008; 14(1):10-8. DOI: 10.1080/13814780701855724
Source: PubMed

ABSTRACT Depression often occurs simultaneously with a variety of somatic, psychiatric, and social conditions. Knowledge about differences in the pharmacological treatment of depressed patients with and without co-morbidity is lacking.
To compare GPs' pharmacological treatment of depressed patients with and without co-morbidity.
Data were extracted from the computerized medical records of 77 general practices participating in the Dutch National Information Network of General Practice (LINH). We used diagnosis and prescription data of newly diagnosed depressed patients aged 18-65 years (n=4372). A mixed-model technique was used for analyzing the medical data.
During the year after diagnosing depression, depressed patients who also suffered from chronic somatic or psychiatric morbidity were prescribed more psychotropics than patients with depression only. Prescription patterns of psychotropic drugs for depressed patients with and without co-morbid social problems differed only during the first 3 months after diagnosis. For the whole 1-year period after diagnosis, the pharmacological treatment of depression in patients with and without co-morbid social problems did not differ.
Our results indicate that chronic somatic or psychiatric co-morbidity in depressed patients leads to higher GP prescription levels of psychotropics, whereas co-morbid social problems do not seem to influence GPs' pharmacological treatment decisions for depression.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective This study aimed to identify primary care practice characteristics associated with the quality of depression care in patients with comorbid chronic medical and/or psychiatric conditions. Method Using data from cross-sectional organizational and patient surveys conducted within 61 primary care clinics in Quebec, Canada, the relationships between primary care practice characteristics, comorbidity profile, and the recognition and minimally adequate treatment of depression were assessed using multilevel logistic regression analysis with 824 adults with past-year depression and comorbid chronic conditions. Results Likelihood of depression recognition was higher in clinics where accessibility of mental health professionals was not viewed to be a major barrier to depression care (OR=1.61; 95% CI 1.13-2.30). Four practice characteristics were associated with minimal treatment adequacy: greater use of treatment algorithms for depression (OR=1.77; 95% CI=1.18-2.65), high value given to teamwork (OR=2.48; 95% CI=1.40-4.38), having at least one GP at the clinic devote significant time in practice to mental health (OR=1.54; 95% CI=1.07-2.21), and low perceived barriers to depression care due to inadequate payment models (OR=2.12; 95% CI=1.30-3.46). Conclusions Several primary care practice characteristics significantly influence the quality of care provided to patients with depression and comorbid chronic conditions and should be targeted in quality improvement efforts.
    General hospital psychiatry 01/2014; · 2.67 Impact Factor
  • The European journal of general practice 02/2008; 14(1):2-3.
  • [Show abstract] [Hide abstract]
    ABSTRACT: There are different factors influencing the treatment of depression. An important factor is co-morbidity. We made an analysis of depression treatment within general practice in Estonia as part of the PREDICT study in 2003-2005. The study group consisted of consecutive patients (n=1094), aged 18-75 years, who sought consultation from their family doctor. We found that more antidepressants, anxiolytics, and hypnotics were prescribed to patients with co-morbid mental disorder (odds ratio [95% confidence interval] 5.49 [3.61-8.40], 8.38 [5.33-13.18], and 4.02 [2.30-7.02], respectively) compared to those patients who did not have this disorder.
    The European Journal of General Practice 02/2009; 14(3-4):136-7. · 0.74 Impact Factor

Full-text (2 Sources)

Available from
May 27, 2014